Zacks: Analysts Anticipate MINDBODY Inc (MB) Will Post Quarterly Sales of $63.86 Million
Equities research analysts expect MINDBODY Inc (NASDAQ:MB) to post sales of $63.86 million for the current quarter, Zacks reports. Five analysts have made estimates for MINDBODY’s earnings, with the highest sales estimate coming in at $64.35 million and the lowest estimate coming in at $63.32 million. MINDBODY posted sales of $46.61 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 37%. The firm is scheduled to announce its next quarterly earnings report on Thursday, October 25th.
On average, analysts expect that MINDBODY will report full-year sales of $248.28 million for the current year, with estimates ranging from $246.43 million to $252.52 million. For the next financial year, analysts expect that the company will post sales of $309.44 million per share, with estimates ranging from $300.40 million to $318.49 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover MINDBODY.
MINDBODY (NASDAQ:MB) last issued its earnings results on Tuesday, July 31st. The technology company reported ($0.22) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.18) by ($0.04). The business had revenue of $61.61 million for the quarter, compared to the consensus estimate of $60.48 million. MINDBODY had a negative return on equity of 6.83% and a negative net margin of 11.85%.
NASDAQ:MB traded down $0.25 during trading hours on Tuesday, reaching $36.15. 567,274 shares of the company’s stock were exchanged, compared to its average volume of 787,774. MINDBODY has a 12 month low of $21.57 and a 12 month high of $45.50. The company has a debt-to-equity ratio of 0.86, a quick ratio of 8.10 and a current ratio of 9.61.
In other MINDBODY news, CEO Richard Lee Stollmeyer sold 17,739 shares of MINDBODY stock in a transaction on Monday, July 2nd. The shares were sold at an average price of $38.96, for a total transaction of $691,111.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Luxor Capital Group, Lp bought 65,019 shares of the firm’s stock in a transaction on Wednesday, August 1st. The shares were bought at an average cost of $34.86 per share, with a total value of $2,266,562.34. The disclosure for this purchase can be found here. Insiders sold a total of 91,015 shares of company stock valued at $3,432,613 in the last ninety days. Company insiders own 6.02% of the company’s stock.
Large investors have recently modified their holdings of the business. SG Americas Securities LLC bought a new position in shares of MINDBODY during the 1st quarter valued at $122,000. Sei Investments Co. bought a new position in shares of MINDBODY during the 1st quarter valued at $143,000. Nwam LLC bought a new position in shares of MINDBODY during the 2nd quarter valued at $205,000. Granite Springs Asset Management LLC bought a new position in shares of MINDBODY during the 1st quarter valued at $210,000. Finally, Xact Kapitalforvaltning AB bought a new position in shares of MINDBODY during the 1st quarter valued at $223,000. 91.33% of the stock is owned by institutional investors.
MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.
Featured Story: Trading Penny Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.